APA

Müller M., Altmann A., Sauter M., Lindner T., Jäger D., Rathke H., Herold-Mende C., Marmé F., Babich J., Mier W. & Haberkorn U. (20200420). Preclinical evaluation of peptide-based radiotracers for integrin αvβ6-positive pancreatic carcinoma. : Nuklearmedizin. Nuclear medicine.

Chicago

Müller Martin, Altmann Annette, Sauter Max, Lindner Thomas, Jäger Dirk, Rathke Hendrik, Herold-Mende Christel, Marmé Frederik, Babich John, Mier Walter and Haberkorn Uwe. 20200420. Preclinical evaluation of peptide-based radiotracers for integrin αvβ6-positive pancreatic carcinoma. : Nuklearmedizin. Nuclear medicine.

Harvard

Müller M., Altmann A., Sauter M., Lindner T., Jäger D., Rathke H., Herold-Mende C., Marmé F., Babich J., Mier W. and Haberkorn U. (20200420). Preclinical evaluation of peptide-based radiotracers for integrin αvβ6-positive pancreatic carcinoma. : Nuklearmedizin. Nuclear medicine.

MLA

Müller Martin, Altmann Annette, Sauter Max, Lindner Thomas, Jäger Dirk, Rathke Hendrik, Herold-Mende Christel, Marmé Frederik, Babich John, Mier Walter and Haberkorn Uwe. Preclinical evaluation of peptide-based radiotracers for integrin αvβ6-positive pancreatic carcinoma. : Nuklearmedizin. Nuclear medicine. 20200420.